These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18294843)

  • 1. Use of lantibiotic synthetases for the preparation of bioactive constrained peptides.
    Levengood MR; van der Donk WA
    Bioorg Med Chem Lett; 2008 May; 18(10):3025-8. PubMed ID: 18294843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
    Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
    Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production.
    Chatterjee C; Miller LM; Leung YL; Xie L; Yi M; Kelleher NL; van der Donk WA
    J Am Chem Soc; 2005 Nov; 127(44):15332-3. PubMed ID: 16262372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using expressed protein ligation to probe the substrate specificity of lantibiotic synthetases.
    Zhang X; van der Donk WA
    Methods Enzymol; 2009; 462():117-34. PubMed ID: 19632472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chapter 21. In vitro studies of lantibiotic biosynthesis.
    Li B; Cooper LE; van der Donk WA
    Methods Enzymol; 2009; 458():533-58. PubMed ID: 19374997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the regioselectivity of thioether formation by lacticin 481 synthetase.
    Zhang X; Ni W; van der Donk WA
    Org Lett; 2007 Aug; 9(17):3343-6. PubMed ID: 17650008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids.
    Levengood MR; Kerwood CC; Chatterjee C; van der Donk WA
    Chembiochem; 2009 Mar; 10(5):911-9. PubMed ID: 19222036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Michael-type cyclizations in lantibiotic biosynthesis are reversible.
    Yang X; van der Donk WA
    ACS Chem Biol; 2015 May; 10(5):1234-8. PubMed ID: 25723375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.
    Van Goethem S; Van der Veken P; Dubois V; Soroka A; Lambeir AM; Chen X; Haemers A; Scharpé S; De Meester I; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4159-62. PubMed ID: 18556198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and mechanism of lanthipeptide biosynthetic enzymes.
    van der Donk WA; Nair SK
    Curr Opin Struct Biol; 2014 Dec; 29():58-66. PubMed ID: 25460269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.
    Shimafuji C; Noguchi M; Nishie M; Nagao J; Shioya K; Zendo T; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2015 Dec; 120(6):624-9. PubMed ID: 25971839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutants of the zinc ligands of lacticin 481 synthetase retain dehydration activity but have impaired cyclization activity.
    Paul M; Patton GC; van der Donk WA
    Biochemistry; 2007 May; 46(21):6268-76. PubMed ID: 17480057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges.
    van den Hooven HW; Lagerwerf FM; Heerma W; Haverkamp J; Piard JC; Hilbers CW; Siezen RJ; Kuipers OP; Rollema HS
    FEBS Lett; 1996 Aug; 391(3):317-22. PubMed ID: 8764998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioether bond formation by SPASM domain radical SAM enzymes: Cα H-atom abstraction in subtilosin A biosynthesis.
    Benjdia A; Guillot A; Lefranc B; Vaudry H; Leprince J; Berteau O
    Chem Commun (Camb); 2016 May; 52(37):6249-6252. PubMed ID: 27087315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin.
    Kluskens LD; Kuipers A; Rink R; de Boef E; Fekken S; Driessen AJ; Kuipers OP; Moll GN
    Biochemistry; 2005 Sep; 44(38):12827-34. PubMed ID: 16171398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.
    Krawczyk B; Völler GH; Völler J; Ensle P; Süssmuth RD
    Chembiochem; 2012 Sep; 13(14):2065-71. PubMed ID: 22907786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights.
    Goto Y; Li B; Claesen J; Shi Y; Bibb MJ; van der Donk WA
    PLoS Biol; 2010 Mar; 8(3):e1000339. PubMed ID: 20351769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indoles.
    Breslin HJ; Miskowski TA; Kukla MJ; Leister WH; De Winter HL; Gauthier DA; Somers MV; Peeters DC; Roevens PW
    J Med Chem; 2002 Nov; 45(24):5303-10. PubMed ID: 12431057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the leader sequence for directing lanthionine formation in lacticin 481.
    Patton GC; Paul M; Cooper LE; Chatterjee C; van der Donk WA
    Biochemistry; 2008 Jul; 47(28):7342-51. PubMed ID: 18570437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic investigations of the dehydration reaction of lacticin 481 synthetase using site-directed mutagenesis.
    You YO; van der Donk WA
    Biochemistry; 2007 May; 46(20):5991-6000. PubMed ID: 17455908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.